Literature DB >> 2539212

Factor-independent erythropoietic progenitor cells in leukemia induced by the myeloproliferative leukemia virus.

F Wendling1, J F Penciolelli, M Charon, P Tambourin.   

Abstract

The myeloproliferative leukemia virus (MPLV), a novel murine retroviral complex that does not transform fibroblasts, has been shown to cause an acute leukemia in adult mice accompanied by a progressive polycythemia. The present study demonstrates that, on in vivo inoculation, MPLV induces a rapid suppression of growth factor requirement for in vitro colony formation by both the late and the primitive erythroid progenitor cells. CFU-e-derived erythrocytic colonies developed and differentiated in semi-solid medium without the addition of erythropoietin (Epo). In addition, the formation of CFU-e colonies was not altered by the presence of specific neutralizing Epo antibodies. In the spleen, the CFU-e pool size increased rapidly up to 30-fold. By day 6 postinfection, 100% of these progenitor cells were Epo-independent. The in vivo effects of MPLV-infection on early erythroid progenitor cell compartments were examined in cultures grown for seven days. The concentration of erythroid progenitor cells was twofold elevated in spleen from MPLV-infected mice. As early as day 4 postinfection, 50% of these progenitors produced fully hemoglobinized colonies in serum-free cultures without the addition of interleukin-3 (IL-3) and Epo. Most spontaneous colonies were large and contained up to 10(5) cells per colony. They were composed of either erythroblasts only (16%) or erythroblasts and megakaryocytes (70%); few of them were multipotential (14%). In the marrow, the total number of BFU-e was reduced and only few factor-independent bursts were observed, suggesting a rapid migration of infected progenitors from marrow to spleen. Furthermore, the data show that abnormal erythropoiesis was due to the replication defective MPLV information and was not influenced by the Fv-2 locus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539212

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily.

Authors:  I Vigon; J P Mornon; L Cocault; M T Mitjavila; P Tambourin; S Gisselbrecht; M Souyri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  The human homolog of the myeloproliferative virus maps to chromosome band 1p34.

Authors:  M Le Coniat; M Souyri; I Vigon; F Wendling; P Tambourin; R Berger
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

3.  Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenicity.

Authors:  L Bénit; G Courtois; M Charon; P Varlet; I Dusanter-Fourt; S Gisselbrecht
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Constitutive activation of a variant of the env-mpl oncogene product by disulfide-linked homodimerization.

Authors:  G Courtois; L Bénit; Y Mikaeloff; M Pauchard; M Charon; P Varlet; S Gisselbrecht
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Thrombopoietin activates a STAT5-like factor in hematopoietic cells.

Authors:  C Pallard; F Gouilleux; L Bénit; L Cocault; M Souyri; D Levy; B Groner; S Gisselbrecht; I Dusanter-Fourt
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

6.  Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal.

Authors:  R C Skoda; D C Seldin; M K Chiang; C L Peichel; T F Vogt; P Leder
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.